FRNM — Freenome, Inc.

—
Nasdaq · Health Care · Health Care Providers & Services · CIK 2017526 ·
Last close
$9.82
Market Cap
$1.09B
52W High
$17.50
52W Low
$9.71
ADV30
802,338
Next earnings
—
Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops SimpleScreen™ CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Dec 2025 27,879,000 27,429,000 -37,949,000 -38,269,000 507,053,000 78,558,000 1,770,189,000
Sep 2025 1,035,000 424,000 -65,258,000 -64,469,000 — — —

Balance + Analyst (yfinance extras)

Retained Earnings
—
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$217,864,000
EBITDA
$-70,853,000
Free Cash Flow
—
Enterprise Value
$925,846,848
Total Cash
$429,972,000
Total Debt
$201,659,008
Shares Out
111,500,956
Trailing EPS
$-2.04
Book Value
$4.34
ROE
-35.9%
ROA
-10.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 30,409,000 -223,469,000 -219,343,000 507,053,000 1,770,189,000 -1,263,136,000 -110,669,000
Dec 2024 2,882,000 -291,973,000 -274,421,000 551,920,000 1,606,937,000 -1,055,017,000 -196,367,000

TTM Snapshot

Revenues TTM
$3,091,435
NetIncome TTM
$-762,626
OpCashFlow TTM
—
Assets (Latest)
$85,828,386
Forward EPS
$-2.44

Peers — same industry

TickerNameMarket CapLastDaily %
AHCO AdaptHealth Corp. $1.03B $7.53 —
CSTL CASTLE BIOSCIENCES INC $1.02B $32.98 —
PNTG Pennant Group, Inc. $1.28B $36.50 —
INNV InnovAge Holding Corp. $1.29B $9.42 —
OMDA Omada Health, Inc. $872.90M $14.08 —

News headlines (Yahoo Finance, 1h cache)

Freenome (FRNM) Q3 2026 Earnings Call Transcript
2026-11-17 19:17 · Yahoo
Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference
2026-11-17 14:00 · Yahoo
Freenome Reports Third Quarter 2026 Financial Results
2026-11-10 21:01 · Yahoo
Freenome Soars 11% on Launch of Lung Cancer Blood Test That Makes Screening “Vastly Easier”
2026-10-23 18:23 · Yahoo
Tempus AI And 2 More AI Healthcare Stocks
2026-11-15 06:08 · Yahoo
Freenome Q3 Earnings Call Highlights
2026-11-11 02:14 · Yahoo
Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen™ Lung Test With FDA-Approved SimpleScreen CRC Option
2026-10-20 12:30 · Yahoo
Freenome to Report Third Quarter 2026 Financial Results on November 10, 2026
2026-10-15 20:29 · Yahoo
Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026
2026-10-11 17:00 · Yahoo
FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test
2026-08-12 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.